Alan F List Selected Research

Alan F List Research Topics

Disease

74	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 01/2022 - 08/2005
30	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 10/2021 - 01/2002
27	Neoplasms (Cancer) 01/2022 - 12/2003
18	Anemia 01/2022 - 08/2005
10	Chronic Myelomonocytic Leukemia (Leukemia, Chronic Myelomonocytic) 11/2021 - 01/2002
9	Chromosome Aberrations (Chromosome Abnormalities) 01/2020 - 12/2006
6	Leukemia 11/2021 - 01/2002
5	Thrombocytopenia (Thrombopenia) 01/2020 - 10/2012
5	Disease Progression 01/2017 - 01/2011
4	Chromosome 5q Deletion Syndrome 12/2013 - 05/2005
3	Hematologic Neoplasms (Hematological Malignancy) 01/2021 - 07/2009
3	Primary Myelofibrosis (Myelosclerosis) 03/2018 - 07/2007
2	Neutropenia 10/2021 - 04/2014
2	Pathologic Complete Response 01/2020 - 09/2015
2	Splenomegaly 03/2018 - 12/2017
2	Cytopenia 02/2018 - 12/2008
2	Juvenile Myelomonocytic Leukemia 01/2017 - 06/2013
2	Hypersensitivity (Allergy) 01/2017 - 06/2013
2	Hypoalbuminemia 11/2012 - 03/2011
2	Bone Marrow Failure Disorders 05/2012 - 10/2008
2	Iron Overload 12/2011 - 01/2010
2	Blast Crisis (Blast Phase) 05/2006 - 09/2002
1	Bites and Stings (Sting) 01/2022
1	Inflammation (Inflammations) 01/2022
1	Leukopenia 10/2021
1	Febrile Neutropenia 10/2021
1	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 01/2021
1	Diarrhea 01/2020
1	Fatigue 01/2020
1	Asthenia 01/2020
1	Nausea 01/2020
1	Body Weight (Weight, Body) 01/2020
1	Dizziness (Lightheadedness) 01/2020
1	Adrenal Insufficiency (Adrenal Gland Hypofunction) 01/2019
1	Hypothyroidism 01/2019

Drug/Important Bio-Agent (IBA)

35	Lenalidomide (CC 5013)FDA Link 01/2022 - 12/2006
17	Azacitidine (5 Azacytidine)FDA Link 10/2021 - 02/2010
6	Biomarkers (Surrogate Marker)IBA 01/2022 - 12/2008
6	Pharmaceutical PreparationsIBA 01/2016 - 07/2006
5	Cytarabine (Cytosar-U)FDA LinkGeneric 01/2020 - 08/2009
4	Erythropoietin FDA Link 01/2022 - 01/2007
4	InflammasomesIBA 01/2022 - 12/2016
4	ruxolitinibIBA 11/2021 - 01/2016
4	Proteins (Proteins, Gene)FDA Link 01/2019 - 05/2002
4	CytokinesIBA 06/2013 - 01/2002
3	Biological ProductsIBA 01/2022 - 03/2009
3	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 01/2020 - 06/2013
3	Daunorubicin (Cerubidine)FDA LinkGeneric 01/2020 - 08/2009
3	HematinicsIBA 01/2020 - 01/2010
3	Decitabine FDA Link 03/2015 - 02/2010
3	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2013 - 12/2008
2	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 01/2002
2	Erythropoietin Receptors (Erythropoietin Receptor)IBA 01/2021 - 01/2014
2	Epoetin Alfa (Epogen)FDA Link 01/2021 - 10/2012
2	Hemoglobins (Hemoglobin)IBA 01/2021 - 01/2016
2	Antilymphocyte Serum (Anti-Thymocyte Globulin)IBA 01/2020 - 07/2014
2	Cyclosporine (Ciclosporin)FDA LinkGeneric 01/2020 - 09/2002
2	eltrombopag FDA Link 01/2020 - 01/2016
2	Thalidomide (Thalomid)FDA Link 12/2017 - 11/2007
2	Transcription Factors (Transcription Factor)IBA 01/2017 - 05/2006
2	MicroRNAs (MicroRNA)IBA 03/2013 - 04/2011
2	src-Family KinasesIBA 03/2013 - 06/2008
2	Phosphotransferases (Kinase)IBA 03/2013 - 12/2009
2	Serum AlbuminIBA 11/2012 - 03/2011
2	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 08/2012 - 09/2002
2	IronIBA 06/2012 - 01/2010
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 07/2007 - 06/2004
2	Immunomodulating AgentsIBA 10/2006 - 08/2005
1	GATA Transcription FactorsIBA 01/2022
1	Peptide Hydrolases (Proteases)FDA Link 01/2022
1	Immune Checkpoint InhibitorsIBA 01/2022
1	Carrier Proteins (Binding Protein)IBA 01/2022
1	cyclic guanosine monophosphate-adenosine monophosphateIBA 01/2022
1	eprenetapoptIBA 10/2021
1	MDS 11IBA 10/2021
1	Mitochondrial DNA (mtDNA)IBA 01/2021
1	lenzilumabIBA 01/2020
1	luspaterceptIBA 01/2020
1	selinexorIBA 01/2020
1	trioctyl phosphine oxide (TOPO)IBA 01/2020
1	Protein Isoforms (Isoforms)IBA 01/2020
1	Type II DNA Topoisomerases (Topoisomerase II)IBA 01/2020
1	AnthracyclinesIBA 01/2020
1	glasdegibIBA 01/2019
1	Oncogene Proteins (Oncogene Protein)IBA 01/2019
1	Testosterone (Sustanon)FDA Link 01/2019
1	epacadostatIBA 01/2019
1	Indoleamine-Pyrrole 2,3,-Dioxygenase (Indoleamine 2,3 Dioxygenase)IBA 01/2019
1	EnzymesIBA 01/2019
1	Glucose (Dextrose)FDA LinkGeneric 09/2018
1	PrionsIBA 09/2018
1	Activin Receptors (Activin Receptor)IBA 02/2018
1	ACE-011IBA 02/2018
1	Pravastatin (Pravachol)FDA LinkGeneric 01/2018

Therapy/Procedure

34	Therapeutics 11/2021 - 12/2003
9	Drug Therapy (Chemotherapy) 01/2020 - 03/2011
4	Erythrocyte Transfusion 10/2018 - 08/2005
3	Induction Chemotherapy 01/2020 - 04/2011
2	Stem Cell Transplantation 06/2011 - 05/2005
1	Salvage Therapy 03/2018